The core advantage of this product is its strict impurity control, with heavy metals, arsenic and other harmful impurities controlled at very low levels, ensuring that it will not cause adverse reactions during drug use. The uniform particle size of 10-15μm improves the solubility of the powder in the drug formulation, improving the bioavailability of the drug. It also provides complete drug master file (DMF) documents for global regulatory approval, and offers custom particle size and packaging services to meet the specific needs of different pharmaceutical enterprises. In addition, each batch has complete traceability records, ensuring the safety and reliability of the drug production process.
This pharmaceutical-grade lithium carbonate has the following detailed specifications: Purity: 99.9% (tested by titration and ICP-OES); Particle Size: D50 10-15μm; Moisture Content: ≤0.03%; Heavy Metals Total Content: ≤2ppm; Arsenic Content: ≤1ppm; Cadmium Content: ≤0.5ppm; Lead Content: ≤1ppm; Packaging: 25kg food-grade paper drums with inner PE bags for dust-proof and moisture-proof storage; Storage Conditions: Store in a cool, dry place at 2-8°C, avoid direct sunlight and contact with acidic substances; Compliance Standards: Meet USP, EP, BP and GMP production standards.
This product is mainly applicable to the following scenarios: 1. Bipolar disorder treatment drugs: as the core API for antimanic and antidepressant psychiatric drugs; 2. Custom lithium salt pharmaceuticals: used for the production of other lithium-based pharmaceutical raw materials; 3. Pharmaceutical research and development: providing raw material support for new drug R&D and clinical trials; 4. Import and export trade of pharmaceutical raw materials: supplying high-quality pharmaceutical-grade lithium carbonate to global pharmaceutical markets. It can also be used in the production of medical nutritional supplements containing lithium elements.
Post RFQ
Chat
ALL CATEGORIES